Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31665952 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL29862215 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL5426255 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL31665954 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL17932914 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL23528602 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL5671453 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL269039 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL18364678 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL29939047 | 1.00 | TSHR (0.53) | TSHRMAPK1MEN1KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4382588-A1 | ADDITIVES FOR IMPROVING THERMAL STABILITY OF FUELS | BASF SE (DE) | 2024-06-12 | — | — | EP | claimed |
| WO-2024002748-A1 | METHOD FOR MANUFACTURE OF ETHYLENEAMINES | BASF SE (DE) | 2024-01-04 | — | — | WO | claimed |
| CN-114316197-B | Thermoplastic polyurethane adhesive with low polarity and high heat resistance and application thereof | 万华化学集团股份有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-114316197-A | Low-polarity high-heat-resistance thermoplastic polyurethane adhesive and application thereof | 万华化学集团股份有限公司 | 2022-04-12 | — | — | CN | claimed |
| EP-3886904-B1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-3530703-B1 | POLYETHER-MODIFIED SILICONE COMPOSITION, SURFACTANT, FOAM STABILIZER, POLYURETHANE FOAM FORMING COMPOSITION, AND COSMETIC PREPARATION INCLUDING SAID COMPOSITION, AND METHOD FOR PRODUCING SAID COMPOSITION | DOW TORAY CO LTD (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-20250163042-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2025-05-22 | — | — | US | disclosed |
| US-20250136625-A1 | PROCESS FOR THE PREPARATION OF ORGANIC SILICON COMPOUNDS | BASF SE (DE) | 2025-05-01 | — | — | US | disclosed |
| US-12258341-B2 | IRAK degraders and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2025-03-25 | — | — | US | disclosed |
| EP-4476232-A1 | PROCESS FOR THE PREPARATION OF ORGANIC SILICON COMPOUNDS | BASF SE (DE) | 2024-12-18 | — | — | EP | disclosed |
| US-20240409489-A1 | METHOD FOR PRODUCING FLUORINATED POLYETHER | RESONAC CORPORATION (JP) | 2024-12-12 | — | — | US | disclosed |
| WO-2024214529-A1 | MAGNETIC RECORDING MEDIUM LUBRICANT | 株式会社レゾナック | 2024-10-17 | — | — | WO | disclosed |
| US-20020086238-A1 | Capable of forming a planographic plate having excellent plate life; capable of directly being engraved from digital data of a computer or like by recording with solid state laser and a semiconductor laser irradiating infrared rays | FUJIFILM CORPORATION (JP) | 2002-07-04 | — | — | US | disclosed |
| EP-1213619-A1 | Method for preparing lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 2002-06-12 | — | — | EP | disclosed |
| EP-1195646-A1 | Photosensitive lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2002-04-10 | — | — | EP | disclosed |
| US-20010026902-A1 | A support member, a light-to-heat conversion layer that contains a polyurethane with carboxyl group, and a silicone rubber layer; does not generate toxic gas at the time of image formation and printing plate preparation | FUJIFILM CORPORATION (JP) | 2001-10-04 | — | — | US | disclosed |
| EP-1136255-A2 | Image recording material | FUJI PHOTO FILM CO., LTD. (JP) | 2001-09-26 | — | — | EP | disclosed |
| EP-1112843-A2 | Waterless planographic printing plate precursor and production method thereof | FUJI PHOTO FILM CO., LTD. (JP) | 2001-07-04 | — | — | EP | disclosed |
| EP-1096314-A1 | Lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2001-05-02 | — | — | EP | disclosed |
| EP-0949540-A1 | Method for producing lithographic printing plate suitable for laser scan exposure, and photopolymerizable composition | FUJI PHOTO FILM CO., LTD (JP) | 1999-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240409489-A1 | METHOD FOR PRODUCING FLUORINATED POLYETHER | MRPL21, RPS4X, MLX | TSHR 1462/4885MAPK1 2927/4885MEN1 721/4885 |
| US-12258341-B2 | IRAK degraders and uses thereof | IRAK2, IRAK3, IRAK1 | TSHR 3319/4885MAPK1 2017/4885MEN1 4055/4885 |
| US-20250163042-A1 | IRAK DEGRADERS AND USES THEREOF | IRAK2, IRAK3, IRAK1 | TSHR 3319/4885MAPK1 2017/4885MEN1 4055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.